These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Essential familial xanthomatous hypercholesteremia and a therapy trial with triparanol]. MEISINGER FX Arztl Forsch; 1963 Jan; 17():39-44. PubMed ID: 13934599 [No Abstract] [Full Text] [Related]
3. MANAGEMENT OF HYPERCHOLESTEROLEMIA. BLANKENHORN DH; CHIN HP GP; 1964 Apr; 29():135-42. PubMed ID: 14137557 [No Abstract] [Full Text] [Related]
4. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA]. FAIVRE G; GILGENKRANTZ JM; CHERRIER F; HENRY C Coeur Med Interne; 1963 Oct; 58():405-11. PubMed ID: 14092610 [No Abstract] [Full Text] [Related]
5. ATHEROSCLEROSIS AND AORTIC STENOSIS IN HYPERCHOLESTEREMIC XANTHOMATOSIS. KAIN TM J Med Soc N J; 1965 May; 62():176-8. PubMed ID: 14289405 [No Abstract] [Full Text] [Related]
6. [ON THE PATHOGENESIS OF HYPERCHOLESTEREMIC XANTHOMATOSIS]. GREILING H; PETER E; SCHULER B Dtsch Med Wochenschr; 1964 Oct; 89():1887-91. PubMed ID: 14211845 [No Abstract] [Full Text] [Related]
7. The effect of triparanol on the serum lipid pattern in hypercholesteremic patients. KONTTINEN A Acta Med Scand; 1962 Jun; 171():753-7. PubMed ID: 14458285 [No Abstract] [Full Text] [Related]
8. Studies of serum desmosterol levels in hypercholesteremic subjects treated with triparanol (MER-29). Sachs BA; Wolfman L Am J Clin Nutr; 1961; 9():760-3. PubMed ID: 14495832 [No Abstract] [Full Text] [Related]
13. Primary hypercholesteremic xanthomatosis; five cases. OVERHOLT EL Med Bull US Army Eur; 1956 Mar; 13(3):60-4; passim. PubMed ID: 13308465 [No Abstract] [Full Text] [Related]
14. [Considerations on hypercholesteremic xanthomatosis with locomotor manifestations]. STOIA I; STROESCU O; STROESCU I; STANESCU P; BOICESCU L Med Interna (Bucur); 1962 Aug; 14():977-84. PubMed ID: 13984266 [No Abstract] [Full Text] [Related]
15. [Observation of 2 cases of hypercholesteremic tuberous xanthomatosis in children from a small town]. Azúa Dochao L; Tabuenca Oliver JM; Marrón Gasca J Rev Esp Pediatr; 1965; 21(123):259-64. PubMed ID: 5845966 [No Abstract] [Full Text] [Related]
16. [TRITON TEST IN THE STUDY OF HYPOCHOLESTEROLEMIZING ACTIVITY OF TRIPARANOL (MER 29)]. GINOULHIAC E Arch Ital Sci Farmacol; 1964 Jan; 14():64-74. PubMed ID: 14292800 [No Abstract] [Full Text] [Related]
17. [CONGENITAL DISORDERS OF LIPID METABOLISM. X. FAMILIAL HYPERCHOLESTEREMIC XANTHOMATOSIS-DETECTION OF HYPERPROTEINEMIA]. SOBRA J; SEDLAKOVA E; HREBIKOVA A Cas Lek Cesk; 1963 Jun; 102():699-700. PubMed ID: 14054231 [No Abstract] [Full Text] [Related]
18. [JUVENILE XANTHOMATOSIS. DO HYPERCHOLESTEREMIA AND XANTHOMATOSIS FORM A COMPLETE OR AN INCOMPLETE DOMINANT TRAIT?]. NITTER-HAUGE S Tidsskr Nor Laegeforen; 1964 May; 84():823-4. PubMed ID: 14158813 [No Abstract] [Full Text] [Related]
19. Familial hypercholesteremic xanthomatosis: a preliminary report. I. Clinical, electrocardiographic and laboratory considerations. GURAVICH JL Am J Med; 1959 Jan; 26(1):8-29. PubMed ID: 13606149 [No Abstract] [Full Text] [Related]
20. [TRIPARANOL, L-TRIIODOTHYRONINE AND 3-PYRIDYL ACETIC ACID IN THE CONTROL OF CHOLESTEROLEMIA. A COMPARATIVE STUDY]. ARTEAGA A; DIAZ F; TORRES MC; NUNEZ I Rev Med Chil; 1963 Jul; 91():502-7. PubMed ID: 14084440 [No Abstract] [Full Text] [Related] [Next] [New Search]